Juntendo University, Tokyo, Japan
Saturday, 25 May 2024
Novo Nordisk has provided sponsorship to CDNATL to cover the costs of venue hire, subsistence, day delegate rate, AV, stand space for this meeting. Novo Nordisk has had no influence over the meeting agenda/contents, meeting arrangements, speaker or delegate selection.
Pfizer has contributed to the funding of this meeting by way of a grant and has had no control or input into the educational content of this activity, nor the logistics elements, i.e., travel, accommodation, catering, venue selection, or any other aspect of the meeting.
Disclosure of funders is made once contracts are signed and pre-event obligations such as payment have been completed.